Ablacon (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- April 30, 2019
- Vertical
- Healthcare Technology
- Funding URL
- View Funding Page
- Funding Amount:
- $21,500,000
Company Info
- Founders
- Duke Rohlen
- Company Description
- Ablacon is a provider of AI-guided atrial fibrillation therapies.
- Market
- Atrial Fibrillation Diagnosis
- Location
- Wheat Ridge, CO, USA